相关实验视频

Updated: May 12, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.7K

选择性跨动脉化学栓塞治疗不可切除肝细胞癌后肝功能变化:JIVROSG-2001 PRESIDENT-ALBI - 多中心随机对照试验的二次分析

Yoshihisa Kodama1, Masafumi Ikeda2, Yasuaki Arai3

  • 1Center of Interventional Radiology, Keiyukai Sapporo Hospital, Sapporo, Japan.

Liver cancer
|January 15, 2026
PubMed
概括

使用药物释放珠子 (DEB-TACE) 或常规方法 (cTACE) 的转动脉化血栓化 (TACE) 在不可切除的肝细胞癌 (HCC) 患者中不会显著损害肝功能. 更大的瘤和更多受治疗的血管与暂时的肝功能下降有关.

关键词:
这是ALBI级别的ALBI级别.肝细胞癌是肝细胞癌.肝功能 肝功能 肝功能肝功能储备 肝功能储备 肝功能储备通过动脉化学栓塞的跨动脉化疗.

更多相关视频

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach13:57

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach

Published on: May 23, 2025

998

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...